Title:
COMBINATION PREPARATION CONTAINING HETEROCYCLIDENE ACETAMIDE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2024/071349
Kind Code:
A1
Abstract:
The present disclosure provides a suspension-type ophthalmic solution having excellent re-dispersibility. More specifically, the present disclosure provides a water-based suspension preparation containing a first component and a second component, in which the first component is (E)-2-(7-trifluoromethylchroman-4-ylidene)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide or a pharmaceutically acceptable salt or solvate thereof, and the second component comprises at least one component selected from the group consisting of diquafosol, ciclosporin, hyaluronic acid, loteprednol etabonate, bromfenac, fluorometholone and pharmaceutically acceptable salts or solvates thereof.
More Like This:
| JPH05239049 | PYRANYL CYANOGUANIDINE DERIVATIVE |
| WO2006004114 | LIPASE INHIBITOR |
| JP2000264837 | REMOVER OF ALLERGEN AND REMOVING OF ALLERGEN UTILIZING THE SAME |
Inventors:
YAMASHITA YUKI (JP)
Application Number:
PCT/JP2023/035548
Publication Date:
April 04, 2024
Filing Date:
September 28, 2023
Export Citation:
Assignee:
SENJU PHARMA CO (JP)
MOCHIDA PHARM CO LTD (JP)
MOCHIDA PHARM CO LTD (JP)
International Classes:
A61K31/353; A61K9/10; A61K31/196; A61K31/56; A61K31/57; A61K31/7084; A61K31/728; A61K38/13; A61K47/26; A61K47/34; A61P27/04; A61P43/00
Attorney, Agent or Firm:
KAMADA, Mitsunori et al. (JP)
Download PDF: